63.455  -1.745 (-2.68%)		07-31 15:58
Open: 63.465 High: 63.915 Volume: 27,182		Pre. Close: 65.2 Low: 62.85 Market Cap: 201(M)

Short term
Mid term
Targets	6-month :	77.32	1-year :	80.98
Resists	First :	66.19	Second :	69.33
Pivot price	64.35
Supports	First :	61.11	Second :	50.85
MAs	MA(5) :	63.95	MA(20) :	65.12
	MA(100) :	56.25	MA(250) :	49.38
MACD	MACD :	0.9	Signal :	1.5
%K %D	K(14,3) :	25.1	D(3) :	22.5
RSI	RSI(14): 51.2
52-week	High :	69.33	Low :	32.35

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ SBIO ] has closed above bottom band by 22.1%. Bollinger Bands are 56.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	64 - 64.31	64.31 - 64.61
Low:	61.93 - 62.32	62.32 - 62.71
Close:	62.72 - 63.35	63.35 - 63.97

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

Sun, 26 Jul 2026
SBIO Dividend: Does ALPS Medical Breakthroughs ETF Pay a Dividend? - GuruFocus

Tue, 21 Jul 2026
How (SBIO) Movements Inform Risk Allocation Models - Stock Traders Daily

Thu, 09 Jul 2026
Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)? - Yahoo Finance

Tue, 07 Jul 2026
SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO) - Seeking Alpha

Thu, 02 Jul 2026
Biotech stocks boost ALPS Medical Breakthroughs... - Pluang

Thu, 02 Jul 2026
Biotech Gives SBIO Its Best Month Since 2023 - ETF Database

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.